Trial description:
An Open-Label, Multi-Centre Phase I/IIa Study Evaluating the Safety and Clinical Activity of Neoantigen Reactive T cells in Patients with Advanced Non-Small Cell Lung Cancer
Contact name:
Dr Gary Doherty
Trial start date:
Tuesday, January 21, 2020
Trial end date:
Sunday, October 31, 2021
Trial tumour type:
Lung
Show on Radiotherapy:
No
